Titan Spine Celebrates 18k Implantations of Interbody Fusion Device

Heather Linder -   Print  |

Mequon, Wis.-based Titan Spine reached an 18,000 implantation milestone for its Endoskeleton interbody fusion device.The company is approaching an annualized sales revenue run-rate of $20 million.

Titan Spine has been growing steadily over the past 12 months, and recently signed a distribution agreement with Biomet.

More Articles on Devices:

Mitek Sports Medicine Launches RIGIDFIX ACL Reconstruction System
Alphatec Spine Loses $14.5M in Q3 After PurGen Device Discontinuation
DMP Spine Biologics to Distribute Bacterin Bone Graft Products in Europe

© Copyright ASC COMMUNICATIONS 2020. Interested in LINKING to or REPRINTING this content? View our policies here.

Featured Webinars

Featured Whitepapers